Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Dynamic light scattering spectroscopy of the human eye / / Jeffrey N. Weiss
| Dynamic light scattering spectroscopy of the human eye / / Jeffrey N. Weiss |
| Autore | Weiss Jeffrey N. |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (98 pages) |
| Disciplina | 880.9 |
| Soggetto topico | Eye - Diseases - Diagnosis |
| ISBN |
9783031066245
9783031066238 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Chapter 1: Ocular Anatomy -- How Does the Eye Work? -- Chapter 2: Light Scattering -- Summary of Light Scattering in the Eye -- Cornea -- Lens -- Vitreous -- Retina -- Chapter 3: Dynamic Light Scattering (DLS) Spectroscopy -- Analysis -- Cumulant Method -- CONTIN Algorithm -- Further Reading -- Chapter 4: Animal Experiments -- Chapter 5: Human Studies -- Chapter 6: Neurologic Diseases: Protocol -- Introduction -- Type of Research -- Purpose and Objective of the Study -- Background of the Study -- Study Rationale -- Participant Selection -- Study Design/Method/Procedures -- Summary of Research Design -- Performance of Measurements -- General Side Effects -- Collection and Used of Data -- Analysis of Study Results -- Storage of Data -- Confidentiality of Data -- Risk/Benefit Assessment -- Adverse Events -- Benefits -- Participant Recruitment and Informed Consent -- Recruiting -- Length of Study -- Informed Consent/Assent -- Chapter 7: Neurologic Diseases: Informed Consent -- Introduction -- Terms of the Study -- Reproductive Information for Females -- Benefits/Outcome of Treatment -- Description of Procedure -- Cost -- Collection and Use of Data -- Confidentiality of Records -- Available Information -- Termination -- Participant Statement and Authorization -- Chapter 8: Patents: Apparatus for the Detection of Diabetes and Other Abnormalities Affecting the Lens of the Eye -- Related U.S. Patent Documents -- References Cited [Referenced by] -- U.S. Patent Documents -- Other References -- Parent Case Text -- Cross-reference to Related Applications -- Claims -- I Claim -- Description -- Field of the Invention -- Background of the Invention -- Summary of the Invention -- Brief Description of the Drawings -- Detailed Description of the Preferred Embodiment -- Chapter 9: Patents: Diabetes Detection Method #1.
Related U.S. Patent Documents -- Other References -- Parent Case Text -- Cross-reference to Related Applications -- Claims -- I Claim -- Description -- Field of the Invention -- Background of the Invention -- Summary of the Invention -- Brief Description of the Drawings -- Detailed Description of the Method -- Chapter 10: Patents: Diabetes Detection Method #2 -- Related U.S. Patent Documents -- References Cited [Referenced by] -- U.S. Patent Documents -- Parent Case Text -- Cross-reference to Related Applications -- Claims -- Description -- Field of the Invention -- Background of the Invention -- Summary of the Invention -- Brief Description of the Drawings -- Detailed Description of the Method -- Chapter 11: Patents: Filed Patent Application-Apparatus and Method for the Detection of Dementia and Retinal Conditions -- Field of the Invention -- Background of the Invention -- Summary of the Invention -- Brief Description of the Drawings -- Detailed Description -- Claims -- Bibliography -- Index. |
| Record Nr. | UNINA-9910616204603321 |
Weiss Jeffrey N.
|
||
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neurologic stem cell surgery / / Jeffrey N. Weiss
| Neurologic stem cell surgery / / Jeffrey N. Weiss |
| Autore | Weiss Jeffrey N. |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XI, 119 p. 5 illus., 4 illus. in color.) |
| Disciplina | 616.02774 |
| Soggetto topico |
Stem cells - Therapeutic use
Cèl·lules mare Neurocirurgia Teràpia cel·lular |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-72420-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Study Protocols and Informed Consent -- 2. Procedure - Additional Patient Explanation -- 3. Some Thoughts -- 4. Other Treatment Modalities. |
| Record Nr. | UNINA-9910483830103321 |
|
Weiss Jeffrey N.
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Orthopedic stem cell surgery / / Jeffrey N. Weiss
| Orthopedic stem cell surgery / / Jeffrey N. Weiss |
| Autore | Weiss Jeffrey N. |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (281 pages) |
| Disciplina | 616.7 |
| Soggetto topico |
Orthopedics
Cèl·lules mare Ortopèdia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-73299-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Part I: Rotator Cuff Repair -- 1: Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Functional Outcome -- Patient-Centered Outcome -- Eligibility -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 2: Bone Marrow-Derived Stem Cells for the Treatment of Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Inclusion Criteria -- Exclusion Criteria -- 3: Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 4: Safety and Efficacy of Adult Adipose-Derived Stem Cell Injection into Partial-Thickness Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 5: Autologous Adult Adipose-Derived Regenerative Cell Injection into Chronic Partial-Thickness Rotator Cuff Tears -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 6: Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 7: Efficacy of Microfragmented Lipoaspirate Tissue in Arthroscopic Rotator Cuff Repair -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 8: Mesenchymal Stem Cells in Rotator Cuff Repair -- Summary.
Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 9: Treatment of Tendon Disease Using Autologous Adipose-Derived Mesenchymal Stem Cells -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 10: Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Criteria -- Inclusion Criteria -- Exclusion Criteria -- Part II: Knee Osteoarthritis -- 11: Impact of Mesenchymal Stem Cells in Knee Osteoarthritis -- Summary -- Intervention -- Outcome Measures -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Knee Osteoarthritis Subjects -- Focal Chondral Defect Subjects -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 12: Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES) -- Summary -- Intervention -- Outcome -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 13: Early Regenerative Intervention for Post-Traumatic Osteoarthritis (ERIPTO) -- Summary -- Intervention -- Outcome Measures -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 14: Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 15: Open-Ended Trocar Vs. Fenestrated Blunt Trocar in Bone Marrow Aspirate for Osteoarthritis -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Eligibility Criteria -- Inclusion Criteria -- Exclusion Criteria. 16: The Effect of Microfragmented Adipose Tissue (MFAT) on Knee Osteoarthritis -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 17: A Disease-Based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-Derived Regenerative Cells -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion -- All Cohorts -- Inclusion Criteria-All Cohorts -- Ankle Cohort -- Hip Cohort -- Knee Cohort -- Shoulder Cohort -- Wrist Cohort -- Exclusion Criteria-All Cohorts -- Ankle Cohort -- Hip Cohort -- Knee Cohort -- Shoulder Cohort -- Wrist Cohort -- 18: Stem Cell and Growth Factor Injury and Arthritis Clinical Research Study -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 19: Adipose-derived Mesenchymal Stem Cells in Osteoarthritis -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Scoring and Interpretation -- Secondary Outcome Measures -- Methods -- Inclusion Criteria -- Exclusion Criteria -- 20: Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Methods -- Inclusion Criteria -- Exclusion Criteria -- 21: A Study Evaluating the Efficacy of a Single Injection Autologous Adipose-Derived Mesenchymal Stromal Cells in Patients with Knee Osteoarthritis (ADIPOA-2) -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 22: Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair (AURA) -- Summary -- Detailed Description -- Primary Outcome Measures. Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 23: Subchondral and Intra-articular Application of Bone Marrow Concentrate for Knee Unicompartmental OA (Marrow Mule) -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 24: Treatment of Early Knee Osteoarthritis with Autologous Adipose-Derived Mesenchymal Stem Cells -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 25: Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 26: Very Small Embryonic-Like Stem Cells for Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 27: Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 28: Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 29: Treatment of Knee Osteoarthritis with Autologous Adipose-Derived Mesenchymal Stem Cells -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 30: Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis -- Summary. Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 31: Mesenchymal Stem Cell Transplantation for Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 32: Effectiveness of Autologous Adipose-Derived Stem Cells in the Treatment of Knee Cartilage Injury -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 33: Adipose-Derived Stem Cells (ADSCs) for Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 34: Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 35: Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients with Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 36: Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 37: Follow-Up Study for Participants of JointStem Clinical Trial -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 38: A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in the Treatment of Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria. 39: Follow-Up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial. |
| Record Nr. | UNINA-9910488710303321 |
|
Weiss Jeffrey N.
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Retinal and optic nerve stem cell surgery / / Jeffrey N. Weiss
| Retinal and optic nerve stem cell surgery / / Jeffrey N. Weiss |
| Autore | Weiss Jeffrey N. |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (IX, 90 p. 22 illus., 21 illus. in color.) |
| Disciplina | 617.735059 |
| Soggetto topico | Retina - Surgery |
| ISBN | 3-030-60850-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Stem Cells, PRP, Definitions, FDA -- 2. History of Retinal Stem Cell Surgery -- 3. Funding -- 4. ClinicalTrials.gov listings -- 5. Study Protocols -- 6. Study Design/Method/Procedures -- 7. Informed Consent -- 8. Procedure - Additional Patient Explanation -- 9. Photos -- 10. Some Thoughts for the Future -- 11. Publications -- 12. Frequently Asked Questions (FAQ). |
| Record Nr. | UNINA-9910484741803321 |
|
Weiss Jeffrey N.
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Stem cell surgery trials in heart failure and diabetes : a concise guide / / Jeffrey N. Weiss
| Stem cell surgery trials in heart failure and diabetes : a concise guide / / Jeffrey N. Weiss |
| Autore | Weiss Jeffrey N. |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (164 pages) |
| Disciplina | 616.46206 |
| Soggetto topico |
Diabetes - Treatment
Stem cells - Transplantation Heart failure - Treatment |
| ISBN |
9783030780104
9783030780098 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Part I: Heart Failure (United States) -- Chapter 1: Bone Marrow-Derived Mesenchymal Stem Cells in Improving Heart Function in Patients with Heart Failure Caused by Anthracyclines -- Chapter 2: Donor Bone Marrow-Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients with Cardiomyopathy Caused by Anthracyclines -- Chapter 3: The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial -- Chapter 4: Regression of Fibrosis and Reversal of Diastolic Dysfunction in HFPEF Patients Treated with Allogeneic CDCs -- Chapter 5: Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure -- Part II: Heart Failure (Europe) -- Chapter 6: Allogeneic Stem Cell Therapy in Heart Failure -- Chapter 7: Stem Cell Therapy in Advanced Heart Failure -- Chapter 8: Stem Cell Therapy in Ischemic Non-treatable Cardiac Disease -- Chapter 9: Infusion Intracoronary of Mononuclear Autologous Adult Non Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients with Idiopathic Dilated Cardiomyopathy and Heart Failure -- Chapter 10: Cell Therapy in HFpEF -- Chapter 11: Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-Derived Mononuclear Cells on Mortality in Patients with Chronic Post-infarction Heart Failure -- Chapter 12: Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients with STEMI -- Chapter 13: Stem Cell Therapy in Non-ischemic, Non-treatable Dilated Cardiomyopathies II: A Pilot Study -- Part III: Heart Failure (Iran) -- Chapter 14: IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients -- Chapter 15: ICMNC-HF: IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients.
Part IV: Heart Failure (China) -- Chapter 16: Treating Heart Failure with hPSC-CMs -- Part V: Diabetes Mellitus: Type 1 Diabetes (United States) -- Chapter 17: Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells -- Chapter 18: A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes -- Chapter 19: Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes -- Chapter 20: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease -- Part VI: Diabetes Mellitus: Type 1 Diabetes (China) -- Chapter 21: Stem Cell Educator Therapy in Diabetes -- Chapter 22: Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy -- Part VII: Diabetes Mellitus: Type 1 Diabetes (China/Spain) -- Chapter 23: Stem Cell Educator Therapy in Type 1 Diabetes -- Part VIII: Diabetes Mellitus: Type 1 Diabetes (South America) -- Chapter 24: Mesenchymal Stem Cells in Patients with Type 1 Diabetes Mellitus -- Part IX: Diabetes Mellitus: Type 1 Diabetes (Canada) -- Chapter 25: Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM) -- Part X: Diabetes Mellitus: Type 1 Diabetes (Middle East) -- Chapter 26: Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Patients (MSCTXT1DM) -- Chapter 27: Use of Stem Cells in Diabetes Mellitus Type 1 -- Part XI: Diabetes Mellitus: Type 1 Diabetes (Sweden) -- Chapter 28: Wharton's Jelly-Derived Mesenchymal Stromal Cell-Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes -- Part XII: Diabetes Mellitus: Type 2 Diabetes (United States) -- Chapter 29: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial Dysfunction in Diabetic Subjects (ACESO) -- Chapter 30: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease -- Part XIII: Diabetes Mellitus: Type 2 Diabetes (China). Chapter 31: Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus -- Chapter 32: Stem Cell Educator Therapy in Diabetes -- Chapter 33: Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy -- Part XIV: Diabetes Mellitus: Type 2 Diabetes (Near East) -- Chapter 34: BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients -- Part XV: Diabetes Mellitus: Type 2 Diabetes (Vietnam) -- Chapter 35: BM-MNC and UC-MSC Infusion for Type 2 Diabetes Mellitus Patients (T2DM) -- Part XVI: Other Thoughts -- Chapter 36: Conclusion -- References -- Index. |
| Record Nr. | UNINA-9910556878103321 |
|
Weiss Jeffrey N.
|
||
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||